Related Experiment Video
Updated: Aug 15, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Intrathecal synthesis of beta-2-microglobulin in multiple sclerosis and aseptic meningo-encephalitis
1Department of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Abstract:
Beta-2-microglobulin (beta 2m) levels were studied in the cerebrospinal fluid (CSF) and plasma of 52 patients with clinically definite multiple sclerosis (MS) and of 14 with aseptic meningo-encephalitis (AM). Reference values for beta 2m were defined in 72 subjects of different age groups with tension headache (TH). Plasma levels of beta 2m increased with age in TH controls, particularly in the older age group, while no significant age variation could be detected for CSF beta 2m. Increased levels of beta 2m were found in the CSF and plasma of AM patients and in the CSF in MS. Calculations of CSF/plasma beta 2m ratios showed higher values in AM, reflecting intrathecal beta 2m synthesis, while only borderline alterations were evident in MS. Demonstration of intrathecal production of beta 2m is an additional CSF finding that may be useful in evaluating, among others, inflammatory nervous system disorders, but it has limited importance in the study of MS patients.
Insights
Beta-2-microglobulin (beta 2m) levels in cerebrospinal fluid (CSF) and plasma were analyzed in multiple sclerosis (MS) and aseptic meningoencephalitis (AM) patients. While elevated beta 2m was found in AM, its role in MS diagnosis is limited.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Beta-2-microglobulin (beta 2m) is a protein found on cell surfaces.
- Elevated beta 2m levels can indicate inflammation or certain cancers.
- Its role in neurological disorders like multiple sclerosis (MS) requires further investigation.
Purpose of the Study:
- To investigate beta-2-microglobulin (beta 2m) levels in cerebrospinal fluid (CSF) and plasma of patients with multiple sclerosis (MS) and aseptic meningoencephalitis (AM).
- To establish reference values for beta 2m in a healthy control group.
- To assess the diagnostic utility of beta 2m and its intrathecal synthesis in differentiating neurological conditions.
Main Methods:
- Collected CSF and plasma samples from 52 MS patients, 14 AM patients, and 72 tension headache (TH) controls.
- Measured beta 2m concentrations in all samples.
- Analyzed age-related variations in beta 2m levels and calculated CSF/plasma beta 2m ratios.
Main Results:
- Plasma beta 2m levels increased with age in TH controls; CSF beta 2m showed no significant age variation.
- Elevated beta 2m was observed in both CSF and plasma of AM patients, and in CSF of MS patients.
- Higher CSF/plasma beta 2m ratios in AM suggested intrathecal beta 2m synthesis, with only borderline changes in MS.
Conclusions:
- Intrathecal production of beta 2m is a potential biomarker for inflammatory nervous system disorders.
- Beta 2m analysis has limited diagnostic importance for multiple sclerosis (MS).
- Aseptic meningoencephalitis (AM) shows significant alterations in beta 2m, indicating its utility in diagnosing such conditions.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction

